These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 10515038

  • 21. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
    Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.
    N Engl J Med; 2003 Aug 28; 349(9):831-6. PubMed ID: 12944568
    [Abstract] [Full Text] [Related]

  • 22. [Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura].
    Yasunaga K, Kokawa T, Fujitake H, Nomura S, Kageyama T, Ohyabu H, Tatsumi N, Im T, Park K, Kawagoe H.
    Rinsho Ketsueki; 1991 Sep 28; 32(9):938-44. PubMed ID: 1719256
    [Abstract] [Full Text] [Related]

  • 23. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb 28; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.
    Hemmila MR, Foley DS, Castle VP, Hirschl RB.
    J Pediatr Surg; 2000 Jun 28; 35(6):967-71; discussion 971-2. PubMed ID: 10873046
    [Abstract] [Full Text] [Related]

  • 27. Intravenous immunoglobulin therapy of immune thrombocytopenia.
    Mehta JB, Singhal SB, Mehta BC.
    J Assoc Physicians India; 1992 May 28; 40(5):340-2. PubMed ID: 1483999
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 28; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
    Andersen JC.
    N Engl J Med; 1994 Jun 02; 330(22):1560-4. PubMed ID: 8177245
    [Abstract] [Full Text] [Related]

  • 38. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN, Coughlin CM, Eron J, Bussel JB.
    Semin Hematol; 1998 Jan 02; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [Abstract] [Full Text] [Related]

  • 39. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
    Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B.
    Haematologica; 2005 Jun 02; 90(6):829-32. PubMed ID: 15951296
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.